Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Pietro Quaglino, Gabriella Fabbrocini et al.|Expert Opinion on Biological Therapy|2020Cited by 43
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registryAndrea Chiricozzi, Clara De Simone, Marco Galluzzo et al.|Allergy|2021Cited by 37
Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in ItalyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi et al.|Journal of the European Academy of Dermatology and Venereology|2020Cited by 32